DSIP, 5mg

$34.00

  • Product name: DSIP
  • Sequence: H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH
  • Molecular Formula: C35H48N10O15
  • Molecular Weight: 848.8 g/mol
  • Research Only: Yes
  • Form: Lyophilized Solid
  • Purity: >99%
  • Storage: Keep refrigerated upon reconstitution

Some COAs may contain redactions of confidential or proprietary information. These redactions do not impact or obscure any analytical data, including compound identity, purity, or test results.

Title Range Discount
3-4 vials 5% off 3 - 4 5%
Tiered Bulk Discount 5 - 7 10%
Tiered Bulk Discount 8 - 11 12%
Tiered Bulk Discount 12 - 15 15%
Tiered Bulk Discount 16 + 20%
Description

Delta sleep-inducing peptide (DSIP) is a naturally occurring neuropeptide composed of nine amino acids (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu). It was first identified in the 1970s in association with sleep-related physiological states. DSIP has since been studied in research settings for its potential involvement in sleep regulation and broader neuroendocrine and physiological processes.

Sleep and Neurophysiology Research

DSIP has been investigated for its relationship with sleep architecture, particularly slow-wave (delta) sleep, a stage of non-REM sleep characterized by low-frequency brain activity. Preclinical and limited clinical studies have explored its effects across multiple species, with findings suggesting variable and species-dependent outcomes.

Research has also examined DSIP’s potential interactions with neurotransmitter systems, including serotonin, dopamine, glutamate, and melatonin, as well as its influence on circadian rhythms and electrophysiological activity. However, its precise biological role remains unclear, and the identification of a specific receptor or gene associated with DSIP has not been fully established.

Pain and Sensory Research

DSIP has been explored in experimental and clinical settings for its potential association with pain perception and modulation. Some studies have reported changes in pain-related parameters and circadian pain thresholds under controlled conditions. These observations suggest possible involvement in neurophysiological pathways related to sensory processing, though findings are inconsistent and require further investigation.

Stress and Withdrawal Research

DSIP has also been studied in the context of stress response and substance withdrawal models. Early clinical and observational studies have reported associations with changes in certain physiological and behavioral symptoms; however, these findings are limited by study design and have not been consistently replicated in larger, controlled trials.

DSIP is not approved by the U.S. Food and Drug Administration for human use. Its safety, efficacy, and pharmacological profile have not been established in approved FDA clinical trials. This compound is intended strictly for laboratory research purposes and is not for human or veterinary use.

Lyophilized Peptides

These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. 

Disclaimer: For Research Purposes only

This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research. The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use. Peptides described here are solely for use in structured scientific study by authorized individuals. We advise consulting with research experts, medical practitioners, or legal counsel prior to any decisions about obtaining or utilizing these peptides. The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount. This notice is dynamic and governs all provided content on research peptides.